Spyre Therapeutics (SYRE) FCF Margin (2015 - 2023)
Spyre Therapeutics (SYRE) posted FCF Margin of 2419.04% for Q2 2023, up 72.84% on a QoQ basis from 8906.06% in Q1 2023, and up 88864.0% year-over-year from N/an in Q2 2022.
Spyre Therapeutics (SYRE) FCF Margin (2015 - 2023) Analysis & Trends
Spyre Therapeutics' FCF Margin history runs 7 years deep, the most recent figure standing at 2419.04% for Q2 2023.
- Quarterly FCF Margin rose 88864.0% year-over-year to 2419.04% in Q2 2023, while the trailing twelve-month figure through Mar 2024 was 15806.83% (down 966812.0% YoY) and the FY2023 annual result came in at 11276.52%, down 783376.0% from the prior year.
- FCF Margin was 2419.04% for Q2 2023 at Spyre Therapeutics, up from 8906.06% in the prior quarter.
- Across five years, FCF Margin topped out at 14.98% in Q2 2021 and bottomed at 10797.62% in Q4 2022.
- A 3-year average of 4075.33% and a median of 2419.04% in 2023 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin tumbled 1026886 bps — and 2023, when it jumped 88864 bps.
- Spyre Therapeutics' FCF Margin stood at 528.76% in 2021, then slumped by 1942 bps to 10797.62% in 2022, then soared by 78 bps to 2419.04% in 2023.
- Business Quant data shows SYRE's FCF Margin at 2419.04% in Q2 2023, 8906.06% in Q1 2023, and 10797.62% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Spyre Therapeutics | 257.83 Mn | 257.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -2,419.04% |
| Mar 31, 2023 | -8,906.06% |
| Dec 31, 2022 | -10,797.62% |
| Sep 30, 2022 | -8,660.34% |
| Jun 30, 2022 | -3,307.68% |
| Mar 31, 2022 | -1,930.98% |
| Dec 31, 2021 | -528.76% |
| Sep 30, 2021 | -142.44% |
| Jun 30, 2021 | 14.98% |
| Jun 30, 2018 | -381.79% |
| Mar 31, 2018 | -498.68% |
| Dec 31, 2017 | -408.90% |
| Sep 30, 2017 | -593.10% |
| Jun 30, 2017 | -404.87% |
| Mar 31, 2017 | -580.75% |
| Dec 31, 2016 | -355.73% |
| Sep 30, 2016 | -510.44% |
| Jun 30, 2016 | -343.85% |
| Mar 31, 2016 | -464.49% |
| Dec 31, 2015 | -55.08% |